Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
ID: 351519Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Public and State Controlled Institutions of Higher Education

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through a cooperative agreement to support the NIGMS Human Genetic Cell Repository (HGCR), managed by the Coriell Institute for Medical Research. This initiative aims to maintain and expand a comprehensive collection of human cell lines and DNA samples, enhancing genetic services and providing these vital resources to qualified biomedical researchers. The repository currently holds over 11,900 cell lines and 5,900 DNA samples, with a maximum funding commitment of $1.75 million annually for up to five years, contingent upon a meritorious application. Interested applicants must adhere to NIH guidelines, with submission deadlines beginning May 10, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) through the National Institute of General Medical Sciences (NIGMS) has announced a non-competitive funding opportunity to support a single award for the Coriell Institute for Medical Research to manage the NIGMS Human Genetic Cell Repository (HGCR). The initiative aims to maintain a comprehensive collection of human cell lines and DNA samples, acquire new specimens, and provide these resources to qualified biomedical researchers. The repository currently holds over 11,900 cell lines and 5,900 DNA samples. Key objectives include enhancing genetic services, expanding the database of cell lines, and implementing sustainability strategies for long-term operations. The project period will last up to five years, with a maximum funding commitment of $1.75 million annually, contingent upon a meritorious application. Eligibility is limited to the Coriell Institute, with specific requirements for diverse representation and inclusivity in research teams. Submission deadlines begin May 10, 2024, and applications must adhere strictly to NIH guidelines. Review criteria focus on the project's significance, investigator expertise, innovation, approach, and operational environment. The funding initiative underscores a commitment to advancing biomedical research by improving access to high-quality cellular resources.
    Similar Opportunities
    Loading similar opportunities...